You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Colorcon
Medtronic
Moodys
Express Scripts

Last Updated: April 4, 2020

DrugPatentWatch Database Preview

Glenmark Pharms Ltd Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for GLENMARK PHARMS LTD, and what generic and branded alternatives to GLENMARK PHARMS LTD drugs are available?

GLENMARK PHARMS LTD has fifty-eight approved drugs.

There are eight tentative approvals on GLENMARK PHARMS LTD drugs.

Summary for Glenmark Pharms Ltd
US Patents:0
Tradenames:48
Ingredients:45
NDAs:58

Drugs and US Patents for Glenmark Pharms Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Pharms Ltd DESONIDE desonide OINTMENT;TOPICAL 209996-001 Sep 15, 2017 AB RX No No   Start Trial   Start Trial
Glenmark Pharms Ltd POTASSIUM CHLORIDE potassium chloride TABLET, EXTENDED RELEASE;ORAL 203562-001 Jul 26, 2016 AB1 RX No No   Start Trial   Start Trial
Glenmark Pharms Ltd NEBIVOLOL HYDROCHLORIDE nebivolol hydrochloride TABLET;ORAL 203821-003 May 25, 2017 DISCN No No   Start Trial   Start Trial
Glenmark Pharms Ltd SEVELAMER HYDROCHLORIDE sevelamer hydrochloride TABLET;ORAL 204724-001 Feb 8, 2019 AB RX No No   Start Trial   Start Trial
Glenmark Pharms Ltd NEBIVOLOL HYDROCHLORIDE nebivolol hydrochloride TABLET;ORAL 203821-002 May 25, 2017 DISCN No No   Start Trial   Start Trial
Glenmark Pharms Ltd OLMESARTAN MEDOXOMIL olmesartan medoxomil TABLET;ORAL 203281-003 May 25, 2017 AB RX No No   Start Trial   Start Trial
Glenmark Pharms Ltd POTASSIUM CHLORIDE potassium chloride CAPSULE, EXTENDED RELEASE;ORAL 202868-001 Jan 19, 2016 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Mallinckrodt
Merck
Medtronic
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.